NCT02813863View on ClinicalTrials.gov

The Drug-drug Interaction of SP2086 and Metformin

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2016

Conditions

Type 2 Diabetes

Interventions

DRUG

SP2086

DRUG

Metformin

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02813863 - The Drug-drug Interaction of SP2086 and Metformin | Biotech Hunter | Biotech Hunter